Share this article on:

Human serum increases CD4 recycling to plasma membranes of in-vitro cultured cells

Perdomo, Maria F.; Vahlne, Anders

doi: 10.1097/QAD.0b013e328362de8c

Department of Laboratory Medicine, Division of Clinical Microbiology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.

Correspondence to Anders Vahlne, MD, PhD, Karolinska Institutet, Stockholm, Sweden. E-mail:

Received 8 April, 2013

Revised 24 April, 2013

Accepted 1 May, 2013

We have previously shown that supplementation of culture media with human serum instead of fetal bovine serum (FBS) increases HIV-1 production in infected TZM-bl cells, mainly by augmentation of viral transcription through activation of members of the AP-1 family [1]. However, certain cytokines are able to modulate the in-vivo and in-vitro expression of CD4 of primary cells, thus directly influencing HIV-1 entry efficiency [2–4]. We therefore aimed to study the effect of human serum on the receptor and co-receptor expression in these cells.

Using flow cytometry, we found that increasing amounts of pooled human serum from healthy donors, in comparison to FBS, directly correlated with a higher intensity of CD4. We found a 40% increase between those cells cultured with 5% or 20% human serum. In contrast, human serum gave a decrease in CXCR4 expression. The levels of CCR5 varied between experiments with a general decrease at higher human serum concentrations in six out nine separate observations. In the three other experiments, no change was observed, possibly due to the limited amounts of CCR5 in these cells (Fig. 1a).

Fig. 1

Fig. 1

The CD4 steady state levels were not affected by human serum over time (Fig. 1b) and they were not dependent on de novo synthesis as the increase with human serum versus FBS was seen also after pretreating the cells with 50 μmol/l cycloheximide (Fig. 1c). This suggested an effect of human serum on the stabilization of the receptor at the cell surface or a role on its recycling [5].

We then tested Sup T1 cells (T-cell derived) in which, unlike TZM-bl cells, the CD4 molecule is stabilized at the cell surface by p56lck [6]. Increasing amounts of human serum or FBS did not alter the CD4 levels in this cell line. However, after treatment with cycloheximide, the CD4 levels were constantly 10–20% higher in those Sup T1 cells that were cultured with 5% or 20% human serum than with FBS (three separate observations; P < 0.05). In these cells, the translation inhibitor treatment might have allowed for the detection of small influences on the receptor's recycling that otherwise would be masked by the stable levels of an anchored CD4. To study whether this difference was indeed due to an effect on CD4 recycling, we treated the Sup T1 cells with 100 nmol/l of phorbol 12, 13dibutyrate (PDBu), which induces receptor internalization. The cells cultured with 20% human serum had a faster recovery of CD4 to baseline levels as compared to those with 20% FBS or serum-free media (Fig. 1d). This was also found for the transferrin receptor (TfR), which is known to undergo continuous recycling (Fig. 1e) [7]. Although this molecule is recycled much faster to the cell surface (<30 min) than the CD4 receptor (>120 min to reach baseline levels) [8], we also found a dose-dependent effect on recycling by human serum.

In infected HIV-1 cells, the nef protein is known to downmodulate CD4 by promoting its internalization to early endosomes followed by degradation by the lysosomes [9,10]. By transfecting TZM-bl cells with an HIV-1 subtype C-nef encoding plasmid, we were able to confirm the impact on recycling as the number of cells detected by flow cytometry expressing baseline levels of CD4 was consistently higher in those samples cultured with human serum than in those with FBS.

As higher receptor levels promote viral infectivity and viral spread, we tested whether an increase in CD4 expression after culture with human serum would result in a higher yield of syncytia. We developed a flow cytometry-based method in which TZM-bl cells were precultured for 48 h with 10% FBS or 10% human serum and thereafter co-cultured with chronically infected ACH-2 cells stained with carboxyfluorescein succinimidyl ester (Invitrogen, Carlsbad, California, USA). Fusion of the two cell populations would result in transfer of the intracellular dye from the infected cells to the TZM-bl cells. We found that, in comparison with the cells cultured in 10% FBS, those cultured with 10% human serum always gave a 20–30% increase in syncytia formation (five separate observations; P < 0.05).

Our findings illustrate effects on the cells that are underestimated by common cell culture methods. Moreover, they highlight the importance of having proper controls when performing studies on viral pathogenicity and neutralization to avoid unintended bias in the interpretation of the results. We have not yet explored the reason for the negative effect that human serum had on the surface expression of the co-receptor CXCR4 and possibly also CCR5.

Back to Top | Article Outline


Conflicts of interest

There are no conflicts of interest.

Back to Top | Article Outline


1. Perdomo MF, Hosia W, Jejcic A, Corthals GL, Vahlne A. Human serum protein enhances HIV-1 replication and up-regulates the transcription factor AP-1. Proc Natl Acad Sci USA 2012; 109:17639–17644.
2. Lee B, Sharron M, Montaner LJ, Weissman D, Doms RW. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc Natl Acad Sci USA 1999; 96:5215–5220.
3. Chieco-Bianchi L, Calabro ML, Panozzo M, De Rossi A, Amadori A, Callegaro L, et al. CD4 modulation and inhibition of HIV-1 infectivity induced by monosialoganglioside GM1 in vitro. AIDS 1989; 3:501–507.
4. Wang J, Roderiquez G, Oravecz T, Norcross MA. Cytokine regulation of human immunodeficiency virus type 1 entry and replication in human monocytes/macrophages through modulation of CCR5 expression. J Virol 1998; 72:7642–7647.
5. Pelchen-Matthews A, Armes JE, Marsh M. Internalization and recycling of CD4 transfected into HeLa and NIH3T3 cells. EMBO J 1989; 8:3641–3649.
6. Laguette N, Bregnard C, Bouchet J, Benmerah A, Benichou S, Basmaciogullari S. Nef-induced CD4 endocytosis in human immunodeficiency virus type 1 host cells: role of p56lck kinase. J Virol 2009; 83:7117–7128.
7. Dautry-Varsat A, Ciechanover A, Lodish HF. pH and the recycling of transferrin during receptor-mediated endocytosis. Proc Natl Acad Sci USA 1983; 80:2258–2262.
8. Mayor S, Presley JF, Maxfield FR. Sorting of membrane components from endosomes and subsequent recycling to the cell surface occurs by a bulk flow process. J Cell Biol 1993; 121:1257–1269.
9. Kim YH, Chang SH, Kwon JH, Rhee SS. HIV-1 Nef plays an essential role in two independent processes in CD4 down-regulation: dissociation of the CD4-p56(lck) complex and targeting of CD4 to lysosomes. Virology 1999; 257:208–219.
10. Hua J, Blair W, Truant R, Cullen BR. Identification of regions in HIV-1 Nef required for efficient downregulation of cell surface CD4. Virology 1997; 231:231–238.
© 2013 Lippincott Williams & Wilkins, Inc.